Related Experiment Video
Updated: Jan 7, 2026

06:10
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
Published on: March 30, 2020
8.3K
Curcumin-Based Supplement for Vitreous Floaters Post-Nd:YAG Capsulotomy: A Pilot Study
Alex Malandrini1, Giovanni Rubegni1, Davide Marini1
1Ophthalmology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy.
Vision (Basel, Switzerland)
|December 24, 2025
Summary
This study found that a dietary supplement significantly reduced symptomatic vitreous floaters (SVFs) and foreign body sensations after Nd:YAG laser capsulotomy. The supplement, containing specific nutrients, improved vision quality and was well-tolerated by patients.
Area of Science:
- Ophthalmology
- Nutritional Science
- Medical Devices
Background:
- Symptomatic vitreous floaters (SVFs) can occur after Nd:YAG laser capsulotomy.
- Evaluating non-invasive treatments for post-procedural SVFs is crucial.
Purpose of the Study:
- To assess the short-term efficacy of a dietary supplement on SVFs post-Nd:YAG laser capsulotomy.
- To evaluate the supplement's impact on visual function and patient-reported outcomes.
Main Methods:
- A randomized controlled trial with 40 participants experiencing SVFs.
- Treatment group received oral supplement plus standard therapy; control group received standard therapy only.
- Outcomes measured included visual acuity, contrast sensitivity, subjective questionnaires, and novel ultrasound-based vitreous evaluations (MVP, MGI).
Main Results:
- The treatment group showed significant improvements in contrast sensitivity, floater perception, daily activity interference, foreign body sensation, MVP, and MGI compared to the control group.
- Best-corrected visual acuity remained comparable between groups.
- The dietary supplement was well-tolerated.
Conclusions:
- Short-term oral supplementation with vitreous-specific nutrients effectively reduces SVFs and associated symptoms after Nd:YAG capsulotomy.
- This nutritional approach may offer a promising non-invasive therapeutic option for managing post-Nd:YAG capsulotomy SVFs.
More Related Videos
Related Concept Videos
Open Angle Glaucoma: Treatment
920
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
920
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K

